Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Oct 27, 2022

BUY
$1.68 - $3.55 $82,236 - $173,772
48,950 Added 4895000.0%
48,951 $138,000
Q2 2022

Aug 15, 2022

BUY
$1.68 - $3.55 $82,236 - $173,772
48,950 Added 4895000.0%
48,951 $138,000
Q1 2022

Oct 27, 2022

SELL
$3.01 - $5.21 $147,339 - $255,029
-48,950 Reduced 100.0%
1 $0
Q1 2022

May 13, 2022

BUY
$3.01 - $5.21 $3 - $5
1 New
1 $0
Q4 2021

Feb 14, 2022

SELL
$4.03 - $8.42 $274 - $572
-68 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$5.28 - $8.61 $359 - $585
68 New
68 $1,000

About Processa Pharmaceuticals, Inc.


  • Ticker PCSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,856,200
  • Market Cap $18.4M
  • Description
  • Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...
More about PCSA
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.